查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1790461

美国血酮仪市场规模、份额和趋势分析报告：按类型、应用、最终用途和细分市场预测，2025 年至 2033 年

U.S. Blood Ketone Meter Market Size, Share & Trends Analysis Report By Type (Blood Ketone Monitoring, Blood Glucose and Ketone Monitoring, Consumables), By Application, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

美国血酮监测市场概况

美国血酮监测仪市场规模预计在 2024 年为 1.061 亿美元，预计到 2033 年将达到 1.151 亿美元，2025 年至 2033 年的复合年增长率为 0.9%。推动市场成长的因素包括糖尿病盛行率的上升、消费者健康意识的增强以及生酮和低碳水化合物饮食的普及。

成长的动力源于人们对代谢健康管理日益增长的兴趣，尤其是在生酮人群和需要监测的人群中。血酮监测仪用于监测酮水平，例如管理第1型糖尿病 (T1D)、追踪生酮饮食中的营养性酮症，以及支持治疗癫痫等神经系统疾病。 2023年的一项名为「床边毛细血管血酮测量与1型糖尿病未来酮症酸中毒风险预测」的研究，探讨了在空腹、无症状的1型糖尿病患者中，常规床边毛细血管血酮测量能否预测未来发生糖尿病酮症酸中毒 (DKA) 的可能性。

结果表明，常规毛细血管酮体监测有助于识别未来糖尿病酮症酸中毒 (DKA) 高风险族群，凸显了持续酮体监测 (CKM) 等新兴技术在早期疗育和预防方面的潜在价值。随着人们对 DKA 预防意识的不断提高，此类证据有望推动美国血酮仪市场的普及和扩张。

美国血酮监测产业正受到不断发展的医疗服务模式和支付方政策改革的影响。远端医疗的兴起主要得益于新冠疫情，它透过实现远距咨询、即时数据共用和及时治疗调整，使糖尿病管理更加便捷。这项转变有助于更持续地使用血酮监测仪等监测工具，尤其对于管理第1型糖尿病 (T1D) 并坚持生酮饮食的患者。至2024年，美国20岁以下儿童和青少年中将新增约2万例第1型糖尿病 (T1D) 病例。这一增长是由遗传风险、环境因素和早期生活方式的改变（例如饮食和感染疾病）所推动的。

MDPI 2025 研究题为“1 型糖尿病儿童重度糖尿病酮酸症”，强调了一项关于酮体监测的重要发现。研究发现，在早期发现和管理 DKA 方面，血酮检测比尿酮检测更有效。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国血酮仪市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国血酮监测仪市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析
  • 美国血酮仪市场：通路分析

第四章美国血酮仪市场：按类型、估计和趋势分析

  • 类型细分仪表板
  • 美国血酮仪市场：类型变化分析
  • 美国血酮仪市场规模及趋势分析（2021-2033）
  • 血酮监测
  • 监测血糖值和酮体
  • 耗材

第五章美国血酮仪市场：应用、估计与趋势分析

  • 应用程式细分仪表板
  • 美国血酮监测仪市场：应用差异分析
  • 2021-2033年美国血酮仪市场规模及应用趋势分析
  • 人类
  • 兽医

第六章美国血酮仪市场：依最终用途的估计和趋势分析

  • 最终用途细分仪表板
  • 美国血酮仪市场：最终用途差异分析
  • 2021 年至 2033 年美国血酮仪市场规模及趋势分析（依最终用途）
  • 医院
  • 诊断中心
  • 居家照护
  • 其他的

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 2024年主要企业热图分析
  • 公司简介
    • Abbott
    • Apex BIoTechnology Corp.
    • TaiDoc Technology Corporation
    • EKF Diagnostic Holdings plc.
    • Nova Biomedical
    • Keto-Mojo
    • ForaCare, Inc.
    • Nipro
    • I-SENS, Inc
Product Code: GVR-4-68040-679-2

U.S. Blood Ketone Meter Market Summary

The U.S. blood ketone meter market size was estimated at USD 106.1 million in 2024 and is projected to reach USD 115.1 million by 2033, growing at a CAGR of 0.9% from 2025 to 2033. Some of the factors contributing to market growth include the increasing prevalence of diabetes, growing health awareness among consumers and rising adoption of ketogenic and low-carbohydrate diets.

The growth is driven by increasing interest in metabolic health management, particularly within the keto diet community and among people who need to monitor Blood ketone meters are used to monitor ketone levels for managing Type 1 Diabetes (T1D), tracking nutritional ketosis in ketogenic diets, and supporting the treatment of neurological conditions such as epilepsy. A 2023 study titled "Point-of-Care Capillary Blood Ketone Measurements and the Prediction of Future Ketoacidosis Risk in Type 1 Diabetes" investigated whether routine point-of-care capillary blood ketone measurements in fasted, symptom-free individuals with T1D could predict future DKA events.

The findings showed that routine capillary ketone monitoring can help identify individuals at elevated risk of future DKA, highlighting the potential value of emerging technologies such as Continuous Ketone Monitoring (CKM) for early intervention and prevention. With the growing awareness of DKAprevention, such evidence will likely broaden the adoption and expansion of the U.S. blood ketone meter market.

The U.S. blood ketone meter industry is shaped by evolving care delivery models and payer policy reforms. The rise of telehealth, boosted significantly by the COVID-19 pandemic, has made diabetes management more accessible by enabling remote consultations, real-time data sharing, and timely treatment adjustments. This shift supports more consistent use of monitoring tools such as blood ketone meters, especially for patients managing T1D or adhering to ketogenic therapies. In 2024, approximately 20,000 children and adolescents under the age of 20 in the U.S. were newly diagnosed with T1D. This increase is driven by inherited risk, environmental factors, and changes in early-life habits (such as diet and infections).

The MDPI 2025 study titled "Severe Diabetic Ketoacidosis in Children with Type 1 Diabetes" highlighted key findings on ketone monitoring. The study found that blood ketone testing was more effective than urine ketone testing in early DKA detection and management.

U.S. Blood Ketone Meter Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. blood ketone meter market report based on type, application, and end use:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
    • Blood Ketone Monitoring
    • Blood Glucose and Ketone Monitoring
    • Consumables
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
    • Humans
    • Veterinary
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Hospitals
    • Diagnostic Centers
    • Home Care Settings
    • Other

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Application
    • 1.2.3. End use
    • 1.2.4. Gender
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End use Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Blood Ketone Meter Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. U.S. Blood Ketone Meter Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape
  • 3.4. U.S. Blood Ketone Meter Market: Pipeline Analysis

Chapter 4. U.S. Blood Ketone Meter Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. U.S. Blood Ketone Meter Market: Type Movement Analysis
  • 4.3. U.S. Blood Ketone Meter Market Size & Trend Analysis, by type, 2021 - 2033 (USD Million)
  • 4.4. Blood Ketone Monitoring
    • 4.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 4.5. Blood Glucose and Ketone Monitoring
    • 4.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 4.6. Consumables
    • 4.6.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 5. U.S. Blood Ketone Meter Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Blood Ketone Meter Market: Application Movement Analysis
  • 5.3. U.S. Blood Ketone Meter Market Size & Trend Analysis, by Application, 2021 - 2033 (USD Million)
  • 5.4. Humans
    • 5.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 5.5. Veterinary
    • 5.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 6. U.S. Blood Ketone Meter Market: End Use Estimates & Trend Analysis

  • 6.1. End use Segment Dashboard
  • 6.2. U.S. Blood Ketone Meter Market: End Use Movement Analysis
  • 6.3. U.S. Blood Ketone Meter Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Estimates and Forecasts 2021 - 2033 (USD million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 6.6. Home Care Settings
    • 6.6.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Abbott
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Type benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Apex Biotechnology Corp.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Type benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. TaiDoc Technology Corporation
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Type benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. EKF Diagnostic Holdings plc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Type benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Nova Biomedical
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Type benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Keto-Mojo
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Type benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. ForaCare, Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Type benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Nipro
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Type benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. I-SENS, Inc
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Type benchmarking
      • 7.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. blood ketone meter market, by type, 2021 - 2033 (USD Million)
  • Table 3 U.S. blood ketone meter market, by application, 2021 - 2033 (USD Million)
  • Table 4 U.S. blood ketone meter market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. blood ketone meter market: market outlook
  • Fig. 10 U.S. blood ketone meter competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. blood ketone meter market driver impact
  • Fig. 16 U.S. blood ketone meter market restraint impact
  • Fig. 17 U.S. blood ketone meter market strategic initiatives analysis
  • Fig. 18 U.S. blood ketone meter market: type movement analysis
  • Fig. 19 U.S. blood ketone meter market: type outlook and key takeaways
  • Fig. 20 Blood ketone monitoring market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Blood glucose and ketone monitoring market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Consumables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. blood ketone meter market: application movement analysis
  • Fig. 24 U.S. blood ketone meter market: application outlook and key takeaways
  • Fig. 25 Humans estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Veterinary estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. blood ketone meter market: end use movement analysis
  • Fig. 28 U.S. blood ketone meter market: end use outlook and key takeaways
  • Fig. 29 Hospitals estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Diagnostic Centers estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Home care settings estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Others estimates and forecast, 2021 - 2033 (USD Million)